Tools | Bookmark & Share | Make MrWhy My Homepage
MrWhy.com
Go
Total Results: 593 Videos
MrWhy.com » Videos » Www.Ecancer.Tv -
Categories
Science (593)
Page: 1 of 3012345Next Page
Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität,  Giessen, Germany Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany
Channel: www.ecancer.tv
Length: 0
Date: March 01, 2011
Prof Mathias Rummel discusses his research demonstrating the efficacy of bendamustine plus rituximab as a treatment for mantle cell lymphomas (MCL)...
Chair: Prof Meletios Dimopoulos - Univeristy of Athens,  Greece; Prof Hermann Einsele - Medizinische Klinik II, Wurzburg, Germany; Prof Mario Boccadoro - University of Turin, Italy; Dr Maria-Victoria Chair: Prof Meletios Dimopoulos - Univeristy of Athens, Greece; Prof Hermann Einsele - Medizinische Klinik II, Wurzburg, Germany; Prof Mario Boccadoro - University of Turin, Italy; Dr Maria-Victoria
Channel: www.ecancer.tv
Length: 0
Date: March 01, 2011
The panel discuss how the results of recent clinical trials have advanced our understanding of the optimal treatment for multiple myeloma. The deve...
Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität,  Giessen, Germany Prof Mathias Rummel - Klinikum der Justus-Liebig-Universität, Giessen, Germany
Channel: www.ecancer.tv
Length: 0
Date: March 01, 2011
Prof Mathias Rummel talks about the history of bendamustine from its origins in 1960’s East Germany to the modern trials evaluating the use of bend...
Prof Antonio Palumbo - Molinette Hospital,  Turin, Italy and Prof Vincent Rajkumar - Mayo Clinic, Arizona, USA Prof Antonio Palumbo - Molinette Hospital, Turin, Italy and Prof Vincent Rajkumar - Mayo Clinic, Arizona, USA
Channel: www.ecancer.tv
Length: 0
Date: March 01, 2011
Prof Antonio Palumbo and Prof Vincent Rajkumar discuss some of the key research into myeloma that was presented at ASH 2010. This includes trials d...
Prof Anton Hagenbeek - Academic Medical Center,  Amsterdam, Netherlands Prof Anton Hagenbeek - Academic Medical Center, Amsterdam, Netherlands
Channel: www.ecancer.tv
Length: 0
Date: February 23, 2011
Prof Anton Hagenbeek discusses the five and a half year results of the First-Line Indolent Trial (FIT) study. The randomised phase III FIT study ev...
Prof Valeria Santini - University of Florence,  Italy Prof Valeria Santini - University of Florence, Italy
Channel: www.ecancer.tv
Length: 0
Date: February 21, 2011
Prof Valeria Santini talks about the results of her research on the use of comorbidity indexes to determine prognosis for elderly myelodysplastic s...
Prof Giuseppe Saglio - University of Turin,  Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network Prof Giuseppe Saglio - University of Turin, Italy; Dr Delphine Rea - Saint Louis Hospital, Paris; Jan Geissler - Co-Founder, CML Advocates Network
Channel: www.ecancer.tv
Length: 0
Date: February 21, 2011
The groundbreaking introduction of the tyrosine kinase inhibitor (TKI) imatinib as a treatment for chronic myeloid leukaemia (CML) has been followe...
Prof George Canellos - Harvard Medical School,  Boston, USA Prof George Canellos - Harvard Medical School, Boston, USA
Channel: www.ecancer.tv
Length: 0
Date: February 21, 2011
Prof George Canellos talks about the key research that has emerged from the 2010 ASH meeting in Florida. One trial of note compared the Stanford V ...
Prof Timothy Hughes - Institute of Medical and Veterinary Science,  Adelaide, Australia Prof Timothy Hughes - Institute of Medical and Veterinary Science, Adelaide, Australia
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Prof Timothy Hughes speaks to ecancer.tv about the ENESTnd trial which is evaluating the efficacy and safety of the second generation tyrosine kina...
Dr Reinhard Stauder - Innsbruck Medical University,  Innsbruck, Austria Dr Reinhard Stauder - Innsbruck Medical University, Innsbruck, Austria
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Dr Reinhard Stauder speaks about his aims for the upcoming ecancer meeting on haematological cancers in elderly patients, Rome, 18-20th March 2011...
Dr Michael Keating- MD Anderson Cancer Center,  Texas, USA Dr Michael Keating- MD Anderson Cancer Center, Texas, USA
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Dr Michael Keating discusses his pick of the research presented at ASH 2010. This includes trials looking at new tyrosine kinase inhibitors that ta...
Prof Kanti Rai - Long Island Jewish Medical Center,  New York, USA Prof Kanti Rai - Long Island Jewish Medical Center, New York, USA
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Prof Kanti Rai discusses advances that have been made in the treatment of chronic lymphocytic leukaemia (CLL). Key research presented at this years...
Prof Pieter Sonneveld - Erasmus University Rotterdam,  Netherlands Prof Pieter Sonneveld - Erasmus University Rotterdam, Netherlands
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Prof Pieter Sonneveld speaks about a trial evaluating the efficacy of bortezomib during induction and maintenance therapy on progression-free survi...
Prof Wyndham Wilson - National Cancer Institute,  Maryland, USA Prof Wyndham Wilson - National Cancer Institute, Maryland, USA
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Prof Wyndham Wilson provides a comprehensive summary of the key lymphoma related research presented at the 2010 ASH congress in Florida. The first ...
Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center,  Baltimore, USA Dr William Matsui - Sidney Kimmel Comprehensive Cancer Center, Baltimore, USA
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Dr William Matsui speaks about plasma cell biology and how this affects cancer growth. In multiple myeloma, malignant plasma cells make up the vas...
Jan Geissler - Co-Founder,  CML Advocates Network Jan Geissler - Co-Founder, CML Advocates Network
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Jan Geissler speaks about some of the key research into chronic myeloid leukaemia (CML) that has been presented at ASH 2010. This includes papers o...
Jan Geissler - Co-Founder,  CML Advocates Network Jan Geissler - Co-Founder, CML Advocates Network
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Jan Geissler speaks about the upcoming ecancer meeting on haematological cancers in the elderly which will be held in Rome, 18-20th March 2011. Th...
Dr Jerald Radich - Fred Hutchinson Cancer Research Center,  Seattle, USA Dr Jerald Radich - Fred Hutchinson Cancer Research Center, Seattle, USA
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Dr Jerald Radich speaks about the treatment options that are available for chronic myeloid leukaemia (CML). Tyrosine kinase inhibitors such as imat...
Prof Stephen Baylin - Johns Hopkins University,  Maryland, USA Prof Stephen Baylin - Johns Hopkins University, Maryland, USA
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Prof Stephen Baylin speaks to ecancertv about epigenetics. He explains what epigenetics is, how it is being used to treat cancer and how it may po...
Prof Giuseppe Saglio - University of Turin,  Italy Prof Giuseppe Saglio - University of Turin, Italy
Channel: www.ecancer.tv
Length: 0
Date: February 18, 2011
Prof Giuseppe Saglio speaks about the DASISION trial which compares dasatinib with imatinib as initial treatment for patients with newly diagnosed ...
Page: 1 of 3012345Next Page
 
MrWhy.com Special Offers
1
2
3
4
5
 
About Us: About MrWhy.com | Advertise on MrWhy.com | Contact MrWhy.com | Privacy Policy | MrWhy.com Partners
Answers: Questions and Answers | Browse by Category
Comparison Shopping: Comparison Shopping | Browse by Category | Top Searches
Shop eBay: Shop eBay | Browse by Category
Shop Amazon: Shop Amazon | Browse by Category
Videos: Video Search | Browse by Category
Web Search: Web Search | Browse by Searches
Copyright © 2011 MrWhy.com. All rights reserved.